The global market for infection prevention and control (IPC) is witnessing a robust increase, driven by various contributing factors. The uptick in chronic diseases, an escalation in surgical procedures demanding stringent infection prevention guidelines, the proliferation of hospital-acquired infections, and amplified government initiatives advocating for elevated infection prevention standards are some of these factors. Additionally,…